These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17890655)

  • 1. Hepta and octapeptide agonists of protease-activated receptor 2.
    Devlin MG; Pfeiffer B; Flanagan B; Beyer RL; Cocks TM; Fairlie DP
    J Pept Sci; 2007 Dec; 13(12):856-61. PubMed ID: 17890655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
    Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
    Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
    Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
    Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor-2 peptides activate neurokinin-1 receptors in the mouse isolated trachea.
    Abey HT; Fairlie DP; Moffatt JD; Balzary RW; Cocks TM
    J Pharmacol Exp Ther; 2006 May; 317(2):598-605. PubMed ID: 16434565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo.
    Kawabata A; Kanke T; Yonezawa D; Ishiki T; Saka M; Kabeya M; Sekiguchi F; Kubo S; Kuroda R; Iwaki M; Katsura K; Plevin R
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1098-107. PubMed ID: 14976227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective tryptic cleavage at the tethered ligand site of the amino terminal domain of proteinase-activated receptor-2 in intact cells.
    Al-Ani B; Hollenberg MD
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1120-8. PubMed ID: 12604689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A refined agonist pharmacophore for protease activated receptor 2.
    Barry GD; Suen JY; Low HB; Pfeiffer B; Flanagan B; Halili M; Le GT; Fairlie DP
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5552-7. PubMed ID: 17765542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel agonists and antagonists for human protease activated receptor 2.
    Barry GD; Suen JY; Le GT; Cotterell A; Reid RC; Fairlie DP
    J Med Chem; 2010 Oct; 53(20):7428-40. PubMed ID: 20873792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist.
    McGuire JJ; Saifeddine M; Triggle CR; Sun K; Hollenberg MD
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1124-31. PubMed ID: 14976230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2.
    Kanke T; Ishiwata H; Kabeya M; Saka M; Doi T; Hattori Y; Kawabata A; Plevin R
    Br J Pharmacol; 2005 May; 145(2):255-63. PubMed ID: 15765104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two types of protease-activated receptors (PAR-1 and PAR-2) mediate calcium signaling in rat retinal ganglion cells RGC-5.
    Luo W; Wang Y; Reiser G
    Brain Res; 2005 Jun; 1047(2):159-67. PubMed ID: 15907810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypsin- and SLIGRL-induced vascular relaxation and the inhibition by benzamidine derivatives.
    Glusa E; Saft A; Prasa D; Stürzebecher J
    Thromb Haemost; 1997 Nov; 78(5):1399-403. PubMed ID: 9408026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of peptide agonists for human protease activated receptor 2.
    Stoermer MJ; Flanagan B; Beyer RL; Madala PK; Fairlie DP
    Bioorg Med Chem Lett; 2012 Jan; 22(2):916-9. PubMed ID: 22209488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal administration of proteinase-activated receptor-2 agonists produces hyperalgesia by exciting the cell bodies of primary sensory neurons.
    Alier KA; Endicott JA; Stemkowski PL; Cenac N; Cellars L; Chapman K; Andrade-Gordon P; Vergnolle N; Smith PA
    J Pharmacol Exp Ther; 2008 Jan; 324(1):224-33. PubMed ID: 17921188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinase-activated receptor-2 in rat aorta: structural requirements for agonist activity of receptor-activating peptides.
    Hollenberg MD; Saifeddine M; al-Ani B
    Mol Pharmacol; 1996 Feb; 49(2):229-33. PubMed ID: 8632754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying enhanced vasorelaxant response to protease-activated receptor 2-activating peptide in type 2 diabetic Goto-Kakizaki rat mesenteric artery.
    Matsumoto T; Ishida K; Taguchi K; Kobayashi T; Kamata K
    Peptides; 2009 Sep; 30(9):1729-34. PubMed ID: 19540892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptor 2 (PAR(2)): development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands.
    Al-Ani B; Saifeddine M; Kawabata A; Renaux B; Mokashi S; Hollenberg MD
    J Pharmacol Exp Ther; 1999 Aug; 290(2):753-60. PubMed ID: 10411588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling.
    Compton SJ; Sandhu S; Wijesuriya SJ; Hollenberg MD
    Biochem J; 2002 Dec; 368(Pt 2):495-505. PubMed ID: 12171601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptor-2 (PAR-2)-related peptides induce tear secretion in rats: involvement of PAR-2 and non-PAR-2 mechanisms.
    Nishikawa H; Kawai K; Tanaka M; Ohtani H; Tanaka S; Kitagawa C; Nishida M; Abe T; Araki H; Kawabata A
    J Pharmacol Exp Ther; 2005 Jan; 312(1):324-31. PubMed ID: 15331653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonists of protease-activated receptors 1 and 2 stimulate electrolyte secretion from mouse gallbladder.
    Kirkland JG; Cottrell GS; Bunnett NW; Corvera CU
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G335-46. PubMed ID: 17431214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.